Center for Scientific Review; Amended Notice of Meeting, 67751-67752 [2010-27769]

Download as PDF Federal Register / Vol. 75, No. 212 / Wednesday, November 3, 2010 / Notices Toxicology Testing Service, Inc., 5426 N.W. 79th Ave., Miami, FL 33166, 305– 593–2260. US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755–5235, 301–677–7085. *The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS’ NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on April 30, 2010 (75 FR 22809). After receiving DOT certification, the laboratory will be included in the monthly list of HHScertified laboratories and participate in the NLCP certification maintenance program. Dated: October 28, 2010. Elaine Parry, Director, Office of Management, Technology, and Operations, SAMHSA. [FR Doc. 2010–27728 Filed 11–2–10; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–5055–N] jlentini on DSKJ8SOYB1PROD with NOTICES Medicare Program: Community-Based Care Transitions Program (CCTP) Meeting Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice of meeting. AGENCY: This notice announces a public conference hosted by CMS. This conference will provide a forum for SUMMARY: VerDate Mar<15>2010 19:21 Nov 02, 2010 Jkt 223001 community-based organizations, hospitals, Quality Improvement Organizations, Administration on Aging grantees, and other healthcare providers to receive useful guidance and ask questions about the upcoming Community-based Care Transitions Program. The meeting is open to the public, but attendance is limited to space and Webinar lines available. DATES: Meeting Date: Friday, December 3, 2010, from 8 a.m. to 4 p.m., eastern standard time (e.s.t.). Deadline for Webinar or Web-based Registration: Thursday, December 2, 2010, 8 a.m., e.s.t. Deadline for Meeting Registration: Friday, November 19, 2010, 4 p.m., e.s.t. Limited walk-in registration may be available the evening prior to the conference and the morning of the conference as space permits. ADDRESSES: Meeting Location: Marriott Waterfront Hotel, 700 Aliceanna Street, Baltimore, MD 21202. Registration: The meeting is open to the public, but attendance is limited to space and Webinar lines available. A link to the agenda and registration information will be posted on the CMS Care Transitions Web site at https:// www.cms.gov/DemoProjectsEvalRpts/ MD/ itemdetail.asp?itemID=CMS1239313 as soon as it is available. Persons wishing to attend this meeting in person or via Webinar are encouraged to register in advance. Special Accommodations: Individuals who require special accommodations should send an e-mail request to CareTransitions@cms.hhs.gov or via regular mail to the address specified in the FOR FURTHER INFORMATION CONTACT section of this notice. Presentation materials will be posted on the CMS Care Transitions Web site prior to the meeting. FOR FURTHER INFORMATION CONTACT: Juliana Tiongson, Social Science Research Analyst, Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Baltimore, MD 21244–1850, Mail Stop C4–14–15, telephone 410– 786–0342 or e-mail Juliana.Tiongson@cms.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background Community-based organizations (CBOs) are defined in the statute as community-based organizations that provide care transition services across a continuum of care through arrangements with subsection (d) hospitals (as defined in section 1886(d)(1)(B) of the Social Security Act) and whose governing body includes PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 67751 sufficient representation of multiple health care stakeholders, including consumers. Experts in the field will present evidence-based care transition models, and lessons learned from participation in the Quality Improvement Organizations’ (QIOs) 9th scope of work care transitions subnational theme and related initiatives. Healthcare leaders will present broader, hospital-based interventions to reduce readmissions, as well as the positive financial implications of successfully reducing readmissions. This conference will also provide an overview of the Community-based Care Transitions Program (CCTP) and provide the opportunity for hospitals to connect with CBOs in their communities. Once a solicitation for the CCTP is published, proposals will be accepted on a rolling quarterly basis beginning in early 2011. II. Meeting Agenda The agenda for the December 3, 2010 meeting will include the following topic areas: • Overview of the CCTP under section 3026 of the Affordable Care Act. • The Business Case for Improving Care Transitions. • Building Community Support and Root Cause Analysis. • Overview of Care Transition Interventions. • Implementation of Care Transition Interventions—Successes and Challenges. Authority: Section 3026 of the Affordable Care Act Dated: October 21, 2010. Donald M. Berwick, Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2010–27789 Filed 10–29–10; 4:15 pm] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, November 18, 2010, 2 p.m. to November 18, 2010, 4 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on October 25, 2010, 75 FR 65498–65499. The meeting title has been changed to ‘‘RFA Panel: Translational Research in Pediatric and Obstetric Pharmacology’’. The meeting is closed to the public. E:\FR\FM\03NON1.SGM 03NON1 67752 Federal Register / Vol. 75, No. 212 / Wednesday, November 3, 2010 / Notices Dated: October 28, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. Dated: October 28, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–27769 Filed 11–2–10; 8:45 am] [FR Doc. 2010–27743 Filed 11–2–10; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) National Institutes of Health Centers for Disease Control and Prevention (CDC) Center for Scientific Review; Notice of Closed Meetings jlentini on DSKJ8SOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Devices and Detection Systems. Date: November 17–18, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Allerton Hotel, 701 North Michigan Avenue, Chicago, IL 60611. Contact Person: Ross D Shonat, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6172, MSC 7892, Bethesda, MD 20892. 301–435– 2786. ross.shonat@nih.hhs.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflicts: Voice and Speech. Date: November 22, 2010. Time: 1 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call.) Contact Person: Weijia Ni, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD 20892. (301) 237–9918. niw@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) VerDate Mar<15>2010 19:21 Nov 02, 2010 Jkt 223001 Request for Nominations of Candidates To Serve on the Interagency Committee on Smoking and Health, (ICSH) The ICSH is soliciting nominations for consideration of membership on the committee. This committee provides advice and guidance to the Secretary, HHS, and the Director, CDC regarding (a) coordination of all research and education programs and other activities within the Department and with other federal, State, local and private agencies and (b) establishment and maintenance of liaison with appropriate private entities, federal agencies, and State and local public health agencies with respect to smoking and health activities. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishment of the committee’s objectives. Nominees must meet all of the following mandatory qualifications to be eligible for consideration: Expertise in the field of tobacco control and multi-disciplinary expertise in public health; and knowledge of national health policies and programs managed by HHS. Additionally, desirable qualifications include: (1) Knowledge of emerging tobacco control policies and experience in analyzing, evaluating, and interpreting Federal, State and/or local health or regulatory policy that includes Point of Sale, warning labels, and advertising restrictions; or (2) knowledge of product regulation and the emerging environment of tobacco control and expertise in developing or contributing to the development of policies/or programs; or (3) familiarity of rapid and emerging surveillance systems that will allow for the timely evaluation of tobacco product regulation and/or the impact of tobacco control interventions. Balanced membership will depend upon several factors, including: (1) The committee’s mission; (2) the geographic, ethnic, social, economic, or scientific impact of the advisory committee’s recommendations; (3) the types of specific perspectives required, for PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 example, such as those of consumers, technical experts, the public at-large, academia, business, or other sectors; (4) the need to obtain divergent points of view on the issues before the advisory committee; and (5) the relevance of State, local, or tribal governments to the development of the advisory committee’s recommendations. Members may be invited to serve for up to four-year terms. Nominees must be U.S. citizens. The following information must be submitted for each candidate: name, affiliation, address, telephone number, and current curriculum vitae. E-mail addresses are requested if available. Additionally, the following information must be included: (1) Letter of recommendation stating the nominee’s qualifications; (2) letter of nomination that provides specific attributes that qualify the nominee for service; (3) a statement indicating the nominee’s willingness to serve as a potential member of the Committee; and (4) a narrative addressing the nominee’s experience and professional/technical qualifications. Nominations should be sent electronically or in writing, and postmarked by November 19, 2010 to: Ms. Monica Swann, Committee Management Specialist, NCCDPHP, CDC, 4770 Buford Highway (MS–K 50), Chamblee, Georgia 30341. (E-mail address: zqe0@cdc.gov). Telephone and facsimile submissions cannot be accepted. Candidates invited to serve will be required to submit the Confidential Financial Disclosure Report (OGE 450) form for Special Government Employees (SGEs) serving on Federal Advisory Committees at CDC. This form allows CDC to determine whether there is a statutory conflict between that person’s public responsibilities as a SGE and private interests and activities, or the appearance of a lack of impartiality, as defined by Federal regulation. The form may be viewed and downloaded at https://www.usoge.gov/forms/ oge450_pdf/oge450_accessible.pdf. This form should not be submitted as part of a nomination. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\03NON1.SGM 03NON1

Agencies

[Federal Register Volume 75, Number 212 (Wednesday, November 3, 2010)]
[Notices]
[Pages 67751-67752]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-27769]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, November 18, 2010, 2 p.m. to 
November 18, 2010, 4 p.m., National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892 which was published in the Federal 
Register on October 25, 2010, 75 FR 65498-65499.
    The meeting title has been changed to ``RFA Panel: Translational 
Research in Pediatric and Obstetric Pharmacology''. The meeting is 
closed to the public.


[[Page 67752]]


    Dated: October 28, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-27769 Filed 11-2-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.